Search Results

Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase.

• Authors : Chan BS; School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Department of Clinical Toxicology, Department of Emergency Medicine, Prince of Wales Hospital, Randwick, New South Wales, Australia.

• Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jun 18. Date of Electronic Publication: 2024 Jun 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

Fatal low-dose methotrexate toxicity: A case report and literature review.

• Authors : Ouellette S; Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.; Shah R

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/chemically induced ; Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy

• Source: Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15945. Date of Electronic Publication: 2022 Nov 14.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited

Record details

Methotrexate toxicity in psoriasis-A multicentric retrospective study.

• Authors : Singh GK; Department of Dermatology, Base Hospital, Delhi Cantt, New Delhi, India.; Sapra D

Subjects: Drug-Related Side Effects and Adverse Reactions* ; Methotrexate*/Methotrexate*/Methotrexate*/toxicity ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy

• Source: Dermatologic therapy [Dermatol Ther] 2022 Oct; Vol. 35 (10), pp. e15765. Date of Electronic Publication: 2022 Aug 19.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited

Record details

A Rare Case of Acute Methotrexate Toxicity Leading to Bone Marrow Suppression.

• Authors : Khuwaja, Samreen; Lyons, Matthew; Zulfiqar, Beenish

Subjects: MYELOSUPPRESSION; ECTOPIC pregnancy; ANTIRHEUMATIC agents

• Source: Case Reports in Rheumatology; 3/15/2024, Vol. 2024, p1-4, 4p

Record details

Mucocutaneous ulcers as forerunners of methotrexate toxicity.

• Authors : Tonini G; Department of Medical, Surgical and Neuro-Sciences, Dermatology Unit, University of Siena, Siena, Italy.; Lamberti A

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*adverse effects ; Methotrexate/Methotrexate/Methotrexate/*adverse effects ; Skin Ulcer/Skin Ulcer/Skin Ulcer/*chemically induced

• Source: Dermatologic therapy [Dermatol Ther] 2019 Mar; Vol. 32 (2), pp. e12823. Date of Electronic Publication: 2019 Jan 24.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited

Record details

Methotrexate toxicity presenting as ulcerated psoriatic plaques.

• Authors : Wong SM; Dermatology Unit, Department of Medicine, University Malaya, Kuala Lumpur, Malaysia. ; Chong YT

Subjects: Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*adverse effects ; Methotrexate/Methotrexate/Methotrexate/*adverse effects ; Psoriasis/Psoriasis/Psoriasis/*chemically induced

• Source: The Australasian journal of dermatology [Australas J Dermatol] 2012 Feb; Vol. 53 (1), pp. 81-3. Date of Electronic Publication: 2011 Jun 09.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited

Record details

Advances in individual prediction of methotrexate toxicity: a review.

• Authors : Schmiegelow K; The Faculty of Medicine, Institute of Gynaecology, Obstetrics and Paediatrics, University of Copenhagen, Copenhagen, Denmark.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*drug therapy ; Methotrexate/Methotrexate/Methotrexate/*adverse effects

• Source: British journal of haematology [Br J Haematol] 2009 Sep; Vol. 146 (5), pp. 489-503. Date of Electronic Publication: 2009 Jun 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Acantholytic dermatosis in psoriatic patient with methotrexate toxicity.

• Authors : Sanz-Sánchez T; Romero-Maté A; Tardío JC

Subjects: Acantholysis/Acantholysis/Acantholysis/*chemically induced ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*adverse effects ; Methotrexate/Methotrexate/Methotrexate/*adverse effects

• Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2008 Nov; Vol. 22 (10), pp. 1236-7. Date of Electronic Publication: 2008 Jan Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium:

Record details

Insights into Methotrexate Toxicity in Elderly Patients with Rheumatic Disease.

• Authors : Kaufman, Michele B.

Subjects: METHOTREXATE; RHEUMATISM treatment; ANTIRHEUMATIC agents

• Source: Rheumatologist; Feb2023, p1-3, 3p

Record details

Renal failure: a risk factor for methotrexate toxicity.

• Authors : Chatham WW; The University of Alabama at Birmingham, USA.; Morgan SL

Subjects: Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*drug therapy; Bone Marrow Diseases/Bone Marrow Diseases/Bone Marrow Diseases/chemically induced ; Bone Marrow Diseases/Bone Marrow Diseases/Bone Marrow Diseases/epidemiology

• Source: Arthritis and rheumatism [Arthritis Rheum] 2000 May; Vol. 43 (5), pp. 1185-6.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium:

Record details